Investor

RA Capital Management

Leading life sciences investment fund investing across all stages from seed through public markets

Venture CapitalHealthcare & Biotech

People

Tess Cameronprincipal

News

Interviews (1)

RA Capital's Tess Cameron: biotech stocks rose on EO because market sees it as trade lever, not price control